{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:15:57Z","timestamp":1784034957289,"version":"3.55.0"},"reference-count":13,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dement. neuropsychol."],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>Abstract The diagnosis of Alzheimer's disease (AD) for cases with dementia may be too late to allow effective treatment. Criteria for diagnosis of preclinical AD suggested by the Alzheimer's Association include the use of molecular and structural biomarkers. Preclinical diagnosis will enable testing of new drugs and forms of treatment toward achieving successful preventive treatment. But what are the advantages for the individual? To know that someone who is cognitively normal is probably going to develop AD's dementia when there is no effective preventive treatment is definitely not good news. A research method whereby volunteers are assigned to receive treatment or placebo without knowing whether they are in the control or at-risk arm of a trial would overcome this potential problem. If these new criteria are used wisely they may represent a relevant milestone in the search for a definitive treatment for AD.<\/jats:p>","DOI":"10.1590\/s1980-57642010dn40400002","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T12:35:01Z","timestamp":1469622901000},"page":"259-261","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical diagnosis of Alzheimer's disease: Prevention or prediction?"],"prefix":"10.1590","volume":"4","author":[{"given":"Ricardo","family":"Nitrini","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann G","year":"1984","journal-title":"Neurology"},{"key":"ref2","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994","edition":"4th ed"},{"key":"ref3","series-title":"Delirium, dementia, amnestic, and other cognitive disorders"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen RC","year":"1999","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen RC","year":"2005","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois B","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price JL","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref8","series-title":"Criteria for Preclinical Alzheimer's disease","author":"Sperling R","year":"2010"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack Jr CR","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.wad.0000174993.62494.fb","article-title":"The cure of one of the most frequent types of dementia: a historical parallel","volume":"19","author":"Nitrini R","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref11","series-title":"History of syphilis","author":"Qu\u00e9tel C","year":"1992"},{"key":"ref12","series-title":"Neurosyphilis","author":"Merritt HH","year":"1946"},{"key":"ref13","series-title":"Genetic testing for HD"}],"container-title":["Dementia &amp; Neuropsychologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/dn\/v4n4\/1980-5764-dn-4-04-00259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T22:02:45Z","timestamp":1495576965000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1980-57642010000400259&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1980-57642010000400259"],"URL":"https:\/\/doi.org\/10.1590\/s1980-57642010dn40400002","relation":{},"ISSN":["1980-5764"],"issn-type":[{"value":"1980-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}